Please try another search
| Name | Net % | Long % | Short % |
|---|---|---|---|
| Shares | 100.170 | 100.170 | 0.000 |
| Ratios | Value | Category Average |
|---|---|---|
| P/E Ratio | 12.773 | 18.212 |
| Price to Book | 2.957 | 4.087 |
| Price to Sales | 4.326 | 4.844 |
| Price to Cash Flow | 7.029 | 13.953 |
| Dividend Yield | 0.300 | 0.497 |
| 5 Years Earnings Growth | 1.753 | 8.156 |
Number of long holdings: 39
Number of short holdings: 20
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| Biogen | US09062X1037 | 10.12 | 180.27 | +1.40% | |
| Ionis Pharma | US4622221004 | 10.08 | 81.35 | -0.78% | |
| Crispr Therapeutics | CH0334081137 | 5.41 | 51.58 | -1.13% | |
| Jazz Pharma | IE00B4Q5ZN47 | 4.59 | 166.67 | -3.17% | |
| Swedish Orphan Biovitrum | SE0000872095 | 4.56 | 337.80 | -0.94% | |
| Regeneron Pharma | US75886F1075 | 4.50 | 741.89 | -1.10% | |
| Alkermes Plc | IE00B56GVS15 | 4.34 | 28.97 | +0.24% | |
| Alnylam | US02043Q1076 | 4.31 | 465.07 | +2.31% | |
| Exelixis | US30161Q1040 | 4.30 | 43.44 | +0.02% | |
| Gilead | US3755581036 | 4.26 | 123.90 | -0.35% |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Selectra J Lamarck Biotech Class B | 80.12M | 22.18 | -6.16 | 3.11 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review